This work was partly supported by a Diabetes Australia Research Program grant and the Victoria State Government Operational Infrastructure Support Program, who did not play a role in study design/conduct, analysis/interpretation of data, or manuscript preparation
Avoid taking in case of known allergy to any of the ingredients in the product
The deadline for state-licensed compounding pharmacies and physicians is April 22, 2025, and the deadline for outsourcing facilities is May 22, 2025
[12] The GLP-patches on the market today are technically supplements and are therefore not subject to FDA approval
Up to 55% of patients developed anti-drug antibodies [65], which were associated with systemic allergic reactions in approximately 5% of cases and injection-site hypersensitivity, including anaphylaxis, which necessitated early trial termination [66, 67]